William H Goodson

Summary

Affiliation: California Pacific Medical Center Research Institute
Country: USA

Publications

  1. ncbi Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients
    Shanaz H Dairkee
    California Pacific Medical Center Research Institute, San Francisco, CA 94107, USA
    Cancer Res 68:2076-80. 2008
  2. ncbi Optimization of clinical breast examination
    William H Goodson
    Department of Surgery, California Pacific Medical Center Research Institute, San Francisco, CA, USA
    Am J Med 123:329-34. 2010
  3. ncbi Closure of partial mastectomy
    William H Goodson
    Department of Surgery, California Pacific Medical Center Research Institute, 2100 Webster St, Suite 401, San Francisco, CA 94115, USA
    Am J Surg 191:117-20. 2006
  4. ncbi Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women
    William H Goodson
    California Pacific Medical Center, Research Institute, San Francisco, CA 94107, USA
    Carcinogenesis 32:1724-33. 2011
  5. ncbi Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells
    Maria Gloria Luciani
    California Pacific Medical Center Research Institute, San Francisco, California, United States of America
    PLoS ONE 6:e20016. 2011
  6. ncbi Bisphenol-A-induced inactivation of the p53 axis underlying deregulation of proliferation kinetics, and cell death in non-malignant human breast epithelial cells
    Shanaz H Dairkee
    California Pacific Medical Center Research Institute, 475 Brannan Street, San Francisco, CA 94107, USA
    Carcinogenesis 34:703-12. 2013
  7. ncbi Overall clinical breast examination as a factor in delayed diagnosis of breast cancer
    William H Goodson
    Department of Surgery, California Pacific Medical Research Institute, San Francisco, USA
    Arch Surg 137:1152-6. 2002
  8. ncbi Causes of physician delay in the diagnosis of breast cancer
    William H Goodson
    Department of Surgery, California Pacific Medical Research Institute, 2100 Webster, Suite 401, San Francisco, CA 94115, USA
    Arch Intern Med 162:1343-8. 2002
  9. ncbi New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients
    Holbrook E Kohrt
    Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    BMC Cancer 8:66. 2008
  10. ncbi Ki-67 correlates with in vivo bromodeoxyuridine labeling index in operable breast cancer
    William H Goodson
    J Clin Oncol 24:3809; author reply 3809. 2006

Collaborators

Detail Information

Publications15

  1. ncbi Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients
    Shanaz H Dairkee
    California Pacific Medical Center Research Institute, San Francisco, CA 94107, USA
    Cancer Res 68:2076-80. 2008
    ....
  2. ncbi Optimization of clinical breast examination
    William H Goodson
    Department of Surgery, California Pacific Medical Center Research Institute, San Francisco, CA, USA
    Am J Med 123:329-34. 2010
    ....
  3. ncbi Closure of partial mastectomy
    William H Goodson
    Department of Surgery, California Pacific Medical Center Research Institute, 2100 Webster St, Suite 401, San Francisco, CA 94115, USA
    Am J Surg 191:117-20. 2006
    ....
  4. ncbi Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women
    William H Goodson
    California Pacific Medical Center, Research Institute, San Francisco, CA 94107, USA
    Carcinogenesis 32:1724-33. 2011
    ..Our observations demonstrate the feasibility of studying renewable human samples as surrogates and reinforce the concern that BPA and MP, at low concentrations detected in humans, can have adverse health consequences...
  5. ncbi Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells
    Maria Gloria Luciani
    California Pacific Medical Center Research Institute, San Francisco, California, United States of America
    PLoS ONE 6:e20016. 2011
    ..In this light, early attenuation of epithelial-stromal crosstalk could improve the management of cases prone to be clinically challenging...
  6. ncbi Bisphenol-A-induced inactivation of the p53 axis underlying deregulation of proliferation kinetics, and cell death in non-malignant human breast epithelial cells
    Shanaz H Dairkee
    California Pacific Medical Center Research Institute, 475 Brannan Street, San Francisco, CA 94107, USA
    Carcinogenesis 34:703-12. 2013
    ..We show that BPA exposure induces aberrant expression of multiple checkpoints that regulate cell survival, proliferation and apoptosis and that such changes can be effectively ameliorated...
  7. ncbi Overall clinical breast examination as a factor in delayed diagnosis of breast cancer
    William H Goodson
    Department of Surgery, California Pacific Medical Research Institute, San Francisco, USA
    Arch Surg 137:1152-6. 2002
    ..A standardized description of clinical breast examination (CBE) can predict the risk of delayed diagnosis of breast cancer...
  8. ncbi Causes of physician delay in the diagnosis of breast cancer
    William H Goodson
    Department of Surgery, California Pacific Medical Research Institute, 2100 Webster, Suite 401, San Francisco, CA 94115, USA
    Arch Intern Med 162:1343-8. 2002
    ..Understanding sources of physician delay in diagnosis of breast cancer will assist efforts to expedite diagnosis...
  9. ncbi New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients
    Holbrook E Kohrt
    Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    BMC Cancer 8:66. 2008
    ..Our goal was to develop new models to quantify the risk of NSLN metastasis in SLN-positive patients and to compare predictive capabilities to another widely used model...
  10. ncbi Ki-67 correlates with in vivo bromodeoxyuridine labeling index in operable breast cancer
    William H Goodson
    J Clin Oncol 24:3809; author reply 3809. 2006
  11. ncbi Breast cancer reporting practice and guidelines
    William H Goodson
    J Am Coll Surg 199:170; author reply 171. 2004
  12. ncbi Optimal recall rates following mammography
    William H Goodson
    JAMA 291:821-2; author reply 822. 2004
  13. ncbi Risks of postmenopausal hormone replacement
    William H Goodson
    JAMA 288:2820-1; author reply 2823-4. 2002
  14. ncbi Streamlining clinical breast examination
    William H Goodson
    J Natl Cancer Inst 97:1476-7. 2005
  15. ncbi Molecular prediction of recurrence of breast cancer
    William H Goodson
    N Engl J Med 352:1605-7; author reply 1605-7. 2005